Aroa Biosurgery Embraces Strong Corporate Governance

Aroa Biosurgery Ltd (AU:ARX) has released an update.

Aroa Biosurgery Ltd has affirmed full adherence to the ASX Corporate Governance Council’s recommendations for the 2023-2024 financial year, as detailed in their updated corporate governance statement available on their website. The company has conducted appropriate checks for director and executive appointments and maintained written agreements with them, ensuring transparent management structures and responsibilities.

For further insights into AU:ARX stock, check out TipRanks’ Stock Analysis page.